PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation（PRCT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PRCT · 截至 2026年6月8日
活动摘要
买入笔数
8
P-Purchase only
卖出笔数
40
近12个月
买卖比
0.20
Buy/Sell (by trades)
整体情绪
PROCEPT BioRobotics Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
PRCT 季度内部人买卖趋势
PRCT 内幕交易卖出 · PRCT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · PRCT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PRCT 高管卖出股份 · PRCT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 19, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale | 3,031 | $78K | Form 4 |
| Mar 19, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale | 2,332 | $61K | Form 4 |
| Mar 17, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale | 304 | $9K | Form 4 |
| Mar 17, 2026 | Waters Kevin EVP, CFO | Sale | 706 | $20K | Form 4 |
| Mar 10, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale | 3,098 | $79K | Form 4 |
| Mar 10, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale | 145 | $4K | Form 4 |
| Mar 9, 2026 | Desai Antal Rohit Director | Purchase | 1,300 | $33K | Form 4 |
| Mar 9, 2026 | Desai Antal Rohit Director | Purchase | 53,818 | $1.34M⚡ | Form 4 |
| Mar 9, 2026 | Desai Antal Rohit Director | Purchase | 43,581 | $1.05M⚡ | Form 4 |
| Mar 6, 2026 | Desai Antal Rohit Director | Purchase | 53,763 | $1.30M⚡ | Form 4 |
| Mar 6, 2026 | Desai Antal Rohit Director | Purchase | 106,554 | $2.49M⚡ | Form 4 |
| Mar 5, 2026 | Desai Antal Rohit Director | Purchase | 24,748 | $654K | Form 4 |
| Mar 5, 2026 | Desai Antal Rohit Director | Purchase | 142,498 | $3.63M⚡ | Form 4 |
| Mar 5, 2026 | Wood Larry L President, CEO · Director | Award | 127,783 | — | Form 4 |
| Mar 5, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Award | 43,811 | — | Form 4 |
| Mar 6, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale | 6,892 | $163K | Form 4 |
| Mar 5, 2026 | Waters Kevin EVP, CFO | Award | 47,462 | — | Form 4 |
| Mar 6, 2026 | Waters Kevin EVP, CFO | Sale | 6,721 | $159K | Form 4 |
| Mar 5, 2026 | PUCKETT DAN Director | Award | 5,476 | — | Form 4 |
| Feb 19, 2026 | Nouri Alaleh EVP, CLO, CORP. SEC. | Award | 4,872 | — | Form 4 |
| Feb 19, 2026 | Waters Kevin EVP, CFO | Award | 3,532 | — | Form 4 |
| Sep 2, 2025 | Wood Larry L President, CEO · Director | Award | 182,392 | — | Form 4 |
| Aug 14, 2025 | Desai Antal Rohit Director | Option | 26,749 | $36K | Form 4 |
| Aug 13, 2025 | MOLL FREDERIC H Director | Purchase | 20,000 | $785K | Form 4 |
| Aug 14, 2025 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option | 11,000 | $50K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PRCT 内幕交易
PRCT 内幕交易
PROCEPT BioRobotics Corporation（PRCT）内幕交易数据来源于公司内部人（包括Desai Antal Rohit (Director), Nouri Alaleh (EVP, CLO, CORP. SEC.), Waters Kevin (EVP, CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PRCT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看PROCEPT BioRobotics Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PRCT 内幕交易 · 5个问题PROCEPT BioRobotics Corporation（PRCT）的内部人包括高管和董事，如Desai Antal Rohit (Director), Nouri Alaleh (EVP, CLO, CORP. SEC.), Waters Kevin (EVP, CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026